-
Mashup Score: 7Case receives NCI merit extension - The Cancer Letter - 2 year(s) ago
The Case Comprehensive Cancer Center earned an additional $12 million from NCI as a two-year merit-based extension. The center was the first of two NCI-designated comprehensive cancer centers to be awarded this distinction, followed by Lurie Cancer Center. The center’s Cancer Center Support Grant was last renewed in 2017, when it received an “exceptional” rating […]
Source: The Cancer LetterCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
In celebration of the 50th anniversary of the National Cancer Act, President Biden thanked “the limitless ingenuity of the world’s finest nurses, physicians, and researchers.” Few better exemplify this ingenuity than Fox Chase’s Beatrice Mintz, whose obituary is published in this week’s issue. The Cancer History Project commemorates both this anniversary and the legacy of […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4National Black Family Cancer Awareness Week 2022 PSA - 2 year(s) agoSource: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Commemoration of the 50th Anniversary of the National Cancer Act - 2 year(s) ago
The Division of Cancer Prevention honors the champions and changemakers of cancer prevention, early detection and symptom science. [view:50th_anniversary=50th_anniv_landing] |
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 750 Years of Progress in Treating Patients with Cancer - 2 year(s) ago
50 Years of Progress in Treating Patients with Cancer
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
OCE Director Richard Pazdur, MD, writes about 50 years of progress in treating patients with cancer since the National Cancer Act of 1971 increased the nation’s commitment to cancer research & drug development. #ConversationsOnCancer #NothingWillStopUs https://t.co/sYzaVR9CcS https://t.co/jlGDaX73hO
-
-
Mashup Score: 4Precision Prevention - 2 year(s) ago
A precision approach to prevention could end cancer as we know it by limiting suffering and death for those at risk and helping others avoid unnecessary tests and treatments.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Madhu Sood - 2 year(s) ago
I want to participate in the clinical trial to advance our research and technology. I want to contribute in saving our women in the coming generations. |
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Eshanthika Wijesinha - 2 year(s) ago
I participated in the trial because I wanted to honor the women that had come before and helped me have so many amazing treatment options. I also have friends who stopped taking Tamoxifen because they could not handle the side effects, and I really want my niece and her generation to have better alternatives if they ever need them. |
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Marty Smith - 2 year(s) ago
Living through my sister’s heroic battle with breast cancer and being a woman at high risk, I knew there had to be a better way than “watch and wait”. Prevention became my passion; BCPT my clinical trial to find answers to prevent this disease for my young nieces and all women. Together, through clinical trials, we can prevent breast cancer. |
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Stephania Pemberton - 2 year(s) ago
There are many ways we can create a legacy for our family. There are even fewer opportunities to create a legacy for humanity. Participating in clinical trials gives us a chance to do both. |
Source: Division of Cancer PreventionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
RT @TheCancerLetter: .@caseccc receives @theNCI merit extension. #nothingwillstopus https://t.co/R0XIBa2Fd2 https://t.co/jvnrtH4u2e